Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
The adaptive radiotherapy software market is experiencing notable growth driven by technological advancements and increased demand for precise cancer treatments. As the healthcare sector continues to evolve, this market is set to expand significantly over the coming years. Below, we explore the current market size, key growth factors, segmentation, innovation trends, leading players, and regional dynamics shaping this industry.
Adaptive Radiotherapy Software Market Size and Expected Growth
In recent years, the adaptive radiotherapy software market has expanded quickly, with its value projected to rise from $0.7 billion in 2025 to $0.81 billion in 2026, representing a compound annual growth rate (CAGR) of 14.3%. This upward trend during the historical period is largely attributed to the widespread adoption of image-guided radiotherapy, increasing global cancer incidence, continuous improvements in radiation oncology software, the demand for enhanced treatment precision, and the growth of radiotherapy facilities worldwide. Looking ahead, the market is forecast to reach $1.36 billion by 2030, maintaining a strong CAGR of 14.0%. This future growth is expected to be driven by factors such as the rising demand for personalized cancer therapies, the integration of artificial intelligence (AI) to tailor treatments, expanding use of cloud-based oncology software, greater emphasis on minimizing radiation toxicity, and substantial investments in advanced oncology infrastructure. Emerging trends anticipated to influence the market include adaptive treatment planning, image-guided dose optimization, customized radiation therapy protocols, automation of radiation oncology workflows, and incorporation of multi-modality imaging technologies.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28114&type=smp
Key Factors Fueling Growth in the Adaptive Radiotherapy Software Market
One of the primary drivers behind the market’s expansion is the increasing number of cancer diagnoses worldwide. As populations age and life expectancy rises, the accumulation of genetic mutations heightens the risk of cancer development. Adaptive radiotherapy software plays a critical role in cancer treatment by allowing real-time adjustments of radiation therapy based on changes in tumor size, shape, and patient anatomy. This capability enhances treatment accuracy by maximizing tumor targeting while minimizing harm to surrounding healthy tissue. For example, according to Cancer Australia in February 2025, there were 4,641 new pancreatic cancer cases recorded in 2024 — including 2,414 males and 2,227 females — illustrating the growing cancer burden that is propelling demand for advanced radiotherapy solutions.
Technological Progress and Market Drivers in Adaptive Radiotherapy Software
The expansion of radiotherapy centers globally and the increasing adoption of image-guided radiotherapy techniques have further supported the market’s growth. As healthcare providers seek more effective and precise treatment options, the software’s ability to improve treatment outcomes and patient safety becomes increasingly valuable. The focus on personalized medicine and the integration of AI-driven adaptive therapy approaches are also significant contributors to market momentum, helping clinicians optimize radiation delivery according to individual patient needs.
Adaptive Radiotherapy Software Market Regional Analysis And Leading Geography
Adaptive Radiotherapy Software Market Segmentation Explained
This market is segmented across several key dimensions to provide a comprehensive understanding of its structure. By component, the market includes software and services. Deployment modes are categorized as on-premises and cloud-based solutions. Application-wise, the software is utilized for treating prostate cancer, head and neck cancer, breast cancer, lung cancer, and other types of cancer. End users comprise hospitals, cancer treatment centers, research institutes, and various other medical facilities. Further subsegments within software include treatment planning software, workflow management software, and imaging and visualization software. Meanwhile, services are divided into implementation and integration, maintenance and consulting, as well as training and support.
Innovation Trends Steering Future Development in Adaptive Radiotherapy Software
Leading companies in this field are focusing on the development of cutting-edge technologies such as AI-powered adaptive CT-Linac systems, which combine CT imaging and linear accelerators (Linac) to dynamically optimize radiation delivery based on real-time tumor changes. A notable example is Elekta AB’s launch of Evo in May 2024. This advanced system offers highly personalized cancer radiation therapy with enhanced AI-assisted imaging, enabling clinicians to visualize tumors with exceptional clarity and adjust treatments either during or between sessions. Evo aims to improve the precision of radiotherapy, reduce side effects, enhance patient quality of life, and provide healthcare providers with flexible adoption of innovative technology.
Competitive Landscape of the Adaptive Radiotherapy Software Market
The market features prominent players such as Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Elekta AB, Shanghai United Imaging Healthcare Co. Ltd., United Imaging Healthcare Co. Ltd., Brainlab AG, Accuray Incorporated, RaySearch Laboratories AB, ViewRay Inc., C-RAD AB, Standard Imaging Inc., LAP GmbH Laser Applikationen, Oncology Systems Limited, DOSIsoft SA, Mirada Medical Ltd., Limbus AI, MagnetTx Oncology Solutions Ltd., Spectronic Medical AB, and Akesis Inc. These companies are actively investing in research and development to maintain competitive advantage and meet evolving customer demands.
Geographical Overview and Market Leadership in Adaptive Radiotherapy Software
In 2025, North America was the largest regional market for adaptive radiotherapy software, supported by advanced healthcare infrastructure and high adoption rates of new technologies. Meanwhile, the Asia-Pacific region is expected to register the fastest growth during the forecast period, driven by increasing cancer prevalence, expanding healthcare investments, and greater access to advanced treatment options. The market analysis also covers other important regions including South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a well-rounded perspective on global market dynamics.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
